Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Open-Label Study for the Development of a Method to Detect Dendritic Cell Recruitment in the Human Retina at Sites of Inflammatory Disease and Complement System Activation

NCT06872658 is registered in ClinicalTrials.gov with MindImmune Therapeutics, Inc. as lead sponsor.

NCT NCT06872658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06872658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Open-Label Study for the Development of a Method to Detect Dendritic Cell Recruitment in the Human Retina at Sites of Inflammatory Disease and Complement System Activation
Lead sponsor
MindImmune Therapeutics, Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
May 1, 2025
Completion date
January 1, 2026
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, dry age related macular degeneration, mild cognitive impairment (mci)